Effects of lipopolysaccharide endotoxin on the insulin-like growth factor I system in rats with cirrhosis

In Vivo

Volumn 22, Issue 6, 2008, Pages 655-662

  Thomsen, Karen Louise ^a   Nielsen, Susanne Schouw ^a   Grønbæk, Henning ^a   Flyvbjerg, Allan ^a   Vilstrup, Hendrik ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Endotoxemia; Experimental liver cirrhosis; IGF I; Messenger ribonucleic acid; Rats

Indexed keywords

ENDOTOXIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EXPERIMENTAL LIVER CIRRHOSIS; FEMALE; GENE EXPRESSION; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LIVER CIRRHOSIS; NONHUMAN; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN FUNCTION; RAT; WISTAR RAT;

EID: 57849140793     PISSN: 0258851X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Tessari P: Protein metabolism in liver cirrhosis: from albumin to muscle myofibrils. Curr Opin Clin Nutr Metab Care 6: 79-85, 2003.
2. Borzio M, Salerno F, Piantoni L, Cazzaniga M, Angeli P, Bissoli F, Boccia S, Colloredo-Mels G, Corigliano P, Fornaciari G, Marenco G, Pistara R, Salvagnini M and Sangiovanni A: Bacterial infection in patients with advanced cirrhosis: a multicentre prospective study. Dig Liver Dis 33: 41-48, 2001.
3. Petrides AS, Vogt C, Schulze-Berge D, Matthews D and Strohmeyer G: Pathogenesis of glucose intolerance and diabetes mellitus in cirrhosis. Hepatology 19: 616-627, 1994.
4. Chen JW, Nielsen MF, Caumo A, Vilstrup H, Christiansen JS and Frystyk J: Changes in bioactive IGF-I and IGF-binding protein-1 during an oral glucose tolerance test in patients with liver cirrhosis. Eur J Endocrinol 155: 285-292, 2006.
5. Wu YL, Ye J, Zhang S, Zhong J and Xi RP: Clinical significance of serum IGF-I, IGF-II and IGFBP-3 in liver cirrhosis. World J Gastroenterol 10: 2740-2743, 2004.
6. Donaghy A, Ross R, Gimson A, Hughes SC, Holly J and Williams R: Growth hormone, insulin-like growth factor-1, and insulin-like growth factor-binding proteins 1 and 3 in chronic liver disease. Hepatology 21: 680-688, 1995.
7. Novosyadlyy R, Dargel R and Scharf JG: Expression of insulin-like growth factor-I and insulin-like growth factor-binding proteins during thioacetamide-induced liver cirrhosis in rats. Growth Horm IGF Res 15: 313-323, 2005.
8. Gayan-Ramirez G, van de CM, Rollier H, Fevery J, Vanderhoydonc F, Verhoeven G and Decramer M: Biliary cirrhosis induces type IIx/b fiber atrophy in rat diaphragm and skeletal muscle, and decreases IGF-I mRNA in the liver but not in muscle. J Hepatol 29: 241-249, 1998.
9. Holt RI, Baker AJ, Jones JS, Crossey PA, Stone NM, Preedy VR and Miell JP: Differential effects of malnutrition, bile duct ligation and galactosamine injection in young rats on serum levels and gene expression of IGF-binding proteins. J Endocrinol 149: 465-472, 1996.
10. Fan J, Molina PE, Gelato MC and Lang CH: Differential tissue regulation of insulin-like growth factor-I content and binding proteins after endotoxin. Endocrinology 134: 1685-1692, 1994.
11. Priego T, Granado M, Ibanez dC, I, Martin AI, Villanua MA and Lopez-Calderon A: Endotoxin at low doses stimulates pituitary GH whereas it decreases IGF-I and IGF-binding protein-3 in rats. J Endocrinol 179: 107-117, 2003.
12. Sugita H, Kaneki M, Tokunaga E, Sugita M, Koike C, Yasuhara S, Tompkins RG and Martyn JA: Inducible nitric oxide synthase plays a role in LPS-induced hyperglycemia and insulin resistance. Am J Physiol Endocrinol Metab 282: E386-E394, 2002.
13. Agwunobi AO, Reid C, Maycock P, Little RA and Carlson GL: Insulin resistance and substrate utilization in human endotoxemia. J Clin Endocrinol Metab 85: 3770-3778, 2000.
14. Harry D, Anand R, Holt S, Davies S, Marley R, Fernando B, Goodier D and Moore K: Increased sensitivity to endotoxemia in the bile duct-ligated cirrhotic Rat. Hepatology 30: 1198-1205, 1999.
15. Tygstrup N, Bak S, Krog B, Pietrangelo A and Shafritz DA: Gene expression of urea cycle enzymes following two-thirds partial hepatectomy in the rat. J Hepatol 22: 349-355, 1995.
16. Ballotti R, Nielsen FC, Pringle N, Kowalski A, Richardson WD, Van OE and Gammeltoft S: Insulin-like growth factor I in cultured rat astrocytes: expression of the gene, and receptor tyrosine kinase. EMBO J 6: 3633-3639, 1987.
17. Schuller AG, Groffen C, van Neck JW, Zwarthoff EC and Drop SL: cDNA cloning and mRNA expression of the six mouse insulin-like growth factor binding proteins. Mol Cell Endocrinol 104: 57-66, 1994.
18. Gronbaek H, Frystyk J, Orskov H and Flyvbjerg A: Effect of sodium selenite on growth, insulin-like growth factor-binding proteins and insulin-like growth factor-I in rats. J Endocrinol 145: 105-112, 1995.
19. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S and Binoux M: Analysis of serum insulin-like growth factor-binding proteins using western blotting: use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 154: 138-143, 1986.
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF and Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28: 412-419, 1985.
21. Harry D, Anand R, Holt S, Davies S, Marley R, Fernando B, Goodier D and Moore K: Increased sensitivity to endotoxemia in the bile duct-ligated cirrhotic Rat. Hepatology 30: 1198-1205, 1999.
22. Nielsen SS, Grofte T, Tygstrup N and Vilstrup H: Synthesis of acute phase proteins in rats with cirrhosis exposed to lipopolysaccharide. Comp Hepatol 5: 3, 2006.
23. Nielsen SS, Grofte T, Tygstrup N and Vilstrup H: Cirrhosis and endotoxin decrease urea synthesis in rats. Hepatol Res 37: 540-547, 2007.
24. Lang CH, Pollard V, Fan J, Traber LD, Traber DL, Frost RA, Gelato MC and Prough DS: Acute alterations in growth hormone-insulin-like growth factor axis in humans injected with endotoxin. Am J Physiol 273: R371-R378, 1997.
25. Defalque D, Brandt N, Ketelslegers JM and Thissen JP: GH insensitivity induced by endotoxin injection is associated with decreased liver GH receptors. Am J Physiol 276: E565-E572, 1999.
26. Fan J, Wojnar MM, Theodorakis M and Lang CH: Regulation of insulin-like growth factor (IGF)-I mRNA and peptide and IGF-binding proteins by interleukin-1. Am J Physiol 270: R621-R629, 1996.
27. Fan J, Char D, Bagby GJ, Gelato MC and Lang CH: Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by tumor necrosis factor. Am J Physiol 269: R1204-R1212, 1995.
28. Lang CH, Fan J, Cooney R and Vary TC: IL-1 receptor antagonist attenuates sepsis-induced alterations in the IGF system and protein synthesis. Am J Physiol 270: E430-E437, 1996.
29. Wolf M, Bohm S, Brand M and Kreymann G: Proinflammatory cytokines interleukin 1 beta and tumor necrosis factor alpha inhibit growth hormone stimulation of insulin-like growth factor I synthesis and growth hormone receptor mRNA levels in cultured rat liver cells. Eur J Endocrinol 135: 729-737, 1996.
30. Thissen JP and Verniers J: Inhibition by interleukin-1 beta and tumor necrosis factor-alpha of the insulin-like growth factor I messenger ribonucleic acid response to growth hormone in rat hepatocyte primary culture. Endocrinology 138: 1078-1084, 1997.
31. Ghezzi P, Sacco S, Agnello D, Marullo A, Caselli G and Bertini R: LPS induces IL-6 in the brain and in serum largely through TNF production. Cytokine 12: 1205-1210, 2000.
32. Rechler MM, Ooi GT, Suh D and Tseng L: Rapid regulation of insulin-like growth factor-binding protein-1 transcription by insulin in vivo and in vitro. Adv Exp Med Biol 343: 227-236, 1993.
33. Lang CH and Frost RA: Role of growth hormone, insulin-like growth factor-I, and insulin-like growth factor-binding proteins in the catabolic response to injury and infection. Curr Opin Clin Nutr Metab Care 5: 271-279, 2002.
34. Hrupka BJ and Langhans W: A role for serotonin in lipopolysaccharide-induced anorexia in rats. Pharmacol Biochem Behav 68: 355-362, 2001.
35. Jessen N, Buhl ES, Schmitz O and Lund S: Impaired insulin action despite up-regulation of proximal insulin signaling: novel insights into skeletal muscle insulin resistance in liver cirrhosis. J Hepatol 45: 797-804, 2006.
36. Meyer-Alber A, Hartmann H, Stumpel F and Creutzfeldt W: Mechanism of insulin resistance in CC14-induced cirrhosis of rats. Gastroenterology 102: 223-229, 1992.